Literature DB >> 19868162

THE NEUTRALIZATION OF ANTIPNEUMOCOCCUS IMMUNE BODIES BY INFECTED EXUDATES AND SERA.

R Cole1.   

Abstract

1. In empyema fluids resulting from infection with pneumococci there are present large amounts of soluble substances which have the property of neutralizing pneumococcus antibodies. 2. Similar substances are found in the blood of infected rabbits. 3. When immune serum is injected into infected rabbits the immune substances disappear very quickly, and therefore are prevented from activity in overcoming the infection. 4. When immune serum is administered to patients severely infected with pneumococci, the immune bodies may also disappear very rapidly, and this disappearance is probably associated with the presence of such soluble substances in the blood. 5. The serum only becomes effective when these substances are neutralized. 6. The study of agglutination curves is of value in showing why in certain instances favorable results have not followed the use of immune serum. 7. It is important that in severely injected patients the serum be administered early in the disease and that the initial dosage be large.

Entities:  

Year:  1917        PMID: 19868162      PMCID: PMC2125794          DOI: 10.1084/jem.26.4.453

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  THE MECHANISM OF THE CURATIVE ACTION OF ANTIPNEUMOCOCCUS SERUM.

Authors:  C G Bull
Journal:  J Exp Med       Date:  1915-10-01       Impact factor: 14.307

2.  THE PRESENCE OF PROTECTIVE SUBSTANCES IN HUMAN SERUM DURING LOBAR PNEUMONIA.

Authors:  A R Dochez
Journal:  J Exp Med       Date:  1912-11-01       Impact factor: 14.307

3.  THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

Authors:  A R Dochez; O T Avery
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

  3 in total
  7 in total

1.  Remarks on THE SERUM TREATMENT OF PNEUMONIA.

Authors:  R L Cecil
Journal:  Br Med J       Date:  1932-10-08

2.  ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE.

Authors:  A B Sabin
Journal:  J Exp Med       Date:  1931-01-01       Impact factor: 14.307

3.  IMMUNOLOGICAL RELATIONSHIPS OF CELL CONSTITUENTS OF PNEUMOCOCCUS : SECOND PAPER.

Authors:  O T Avery; M Heidelberger
Journal:  J Exp Med       Date:  1925-08-31       Impact factor: 14.307

4.  A STUDY OF THE THERAPEUTIC MECHANISM OF ANTIPNEUMOCOCCIC SERUM ON THE EXPERIMENTAL DERMAL PNEUMOCOCCUS INFECTION IN RABBITS : I. THE PRESENCE IN ANTIPNEUMOCOCCIC SERUM OF A NON-ANTIBACTERIAL THERAPEUTIC FACTOR.

Authors:  A B Sabin
Journal:  J Exp Med       Date:  1932-09-30       Impact factor: 14.307

5.  STUDIES ON PATHOGENIC B. COLI FROM BOVINE SOURCES : IV. A BIOCHEMICAL STUDY OF THE CAPSULAR SUBSTANCE.

Authors:  D E Smith
Journal:  J Exp Med       Date:  1927-06-30       Impact factor: 14.307

6.  STUDIES ON THE PNEUMONIC EXUDATE : IV. THE PRESENCE IN THE PNEUMONIC LUNG OF A SOLUBLE SUBSTANCE INHIBITING AGGLUTINATION BY THE HOMOLOGOUS SERUM.

Authors:  F T Lord; R N Nye
Journal:  J Exp Med       Date:  1921-07-31       Impact factor: 14.307

7.  IMMUNOLOGICAL REACTIONS OF PNEUMONIC PLEURAL FLUIDS.

Authors:  M Finland
Journal:  J Exp Med       Date:  1932-01-31       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.